Hélder A Santos Selected Research

Nanovaccines

3/2022	Multifunctional Biomimetic Nanovaccines Based on Photothermal and Weak-Immunostimulatory Nanoparticulate Cores for the Immunotherapy of Solid Tumors.
1/2021	Biohybrid Nanosystems for Cancer Treatment: Merging the Best of Two Worlds.
12/2019	Artificially cloaked viral nanovaccine for cancer immunotherapy.
1/2019	Biohybrid Vaccines for Improved Treatment of Aggressive Melanoma with Checkpoint Inhibitor.
2/2017	Multistaged Nanovaccines Based on Porous Silicon@Acetalated Dextran@Cancer Cell Membrane for Cancer Immunotherapy.
1/2017	Delivery of therapeutics with nanoparticles: what's new in cancer immunotherapy?

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Hélder A Santos Research Topics

Disease

62	Neoplasms (Cancer) 03/2022 - 10/2012
16	Breast Neoplasms (Breast Cancer) 10/2021 - 03/2014
8	Inflammation (Inflammations) 03/2022 - 05/2018
8	Infections 01/2022 - 08/2013
8	Wounds and Injuries (Trauma) 10/2021 - 01/2016
4	Myocardial Infarction 02/2020 - 01/2016
4	Type 2 Diabetes Mellitus (MODY) 01/2016 - 11/2014
3	Fibrosis (Cirrhosis) 01/2022 - 09/2014
3	Heart Diseases (Heart Disease) 01/2018 - 09/2014
2	Spinal Cord Injuries (Spinal Cord Injury) 10/2022 - 01/2016
2	Neoplasm Metastasis (Metastasis) 03/2022 - 01/2021
2	Cerebrovascular Disorders (Cerebrovascular Occlusion) 01/2022 - 02/2019
2	Autoimmune Diseases (Autoimmune Disease) 01/2021 - 09/2020
2	Bacterial Infections (Bacterial Infection) 01/2021 - 01/2019
2	Pain (Aches) 01/2021 - 09/2017
2	Melanoma (Melanoma, Malignant) 01/2021 - 01/2019
2	Tuberculosis (Tuberculoses) 12/2020 - 09/2020
2	Inflammatory Bowel Diseases (Inflammatory Bowel Disease) 01/2020 - 12/2018
2	Hypoxia (Hypoxemia) 02/2019 - 04/2017
2	Carcinoma (Carcinomatosis) 01/2019 - 03/2010
2	Virus Diseases (Viral Diseases) 12/2018 - 08/2013
2	Colonic Neoplasms (Colon Cancer) 01/2017 - 12/2013
1	COVID-19 04/2022
1	Cytokine Release Syndrome 04/2022
1	Hyperglycemia 01/2022
1	Thrombosis (Thrombus) 01/2022
1	Weight Gain 01/2022
1	Diabetes Complications 01/2022
1	Liver Cirrhosis (Hepatic Cirrhosis) 01/2022
1	Residual Neoplasm 03/2021
1	Edema (Dropsy) 03/2021

Drug/Important Bio-Agent (IBA)

37	Pharmaceutical PreparationsIBA 10/2022 - 03/2010
21	SiliconIBA 03/2022 - 08/2013
11	Peptides (Polypeptides)IBA 01/2022 - 12/2013
8	Proteins (Proteins, Gene)FDA Link 01/2022 - 01/2017
8	PolymersIBA 05/2020 - 03/2014
7	Biological ProductsIBA 04/2022 - 12/2015
7	Doxorubicin (Adriamycin)FDA LinkGeneric 01/2022 - 01/2016
6	NanovaccinesIBA 03/2022 - 01/2017
5	Liposomes (Liposome)IBA 01/2022 - 12/2019
5	Therapeutic UsesIBA 01/2022 - 04/2015
5	AntigensIBA 09/2020 - 01/2017
4	HydrogelsIBA 04/2022 - 04/2016
4	Hypoglycemic Agents (Hypoglycemics)IBA 01/2022 - 08/2015
4	Sorafenib (BAY 43-9006)FDA Link 03/2021 - 04/2015
4	Cancer VaccinesIBA 10/2020 - 01/2017
4	LipidsIBA 05/2020 - 11/2013
4	Dextrans (Dextran)FDA Link 01/2020 - 02/2017
3	Biocompatible Materials (Biomaterials)IBA 01/2022 - 09/2014
3	Reactive Oxygen Species (Oxygen Radicals)IBA 01/2022 - 03/2010
3	CytokinesIBA 01/2022 - 09/2014
3	DNA (Deoxyribonucleic Acid)IBA 12/2021 - 10/2017
3	GoldIBA 03/2021 - 06/2018
3	LigninIBA 01/2020 - 01/2017
3	CopperIBA 01/2019 - 01/2014
2	Insulin (Novolin)FDA Link 01/2022 - 01/2016
2	1,4,7,10-tetraazacyclododecane- 1,4,7,10-tetraacetic acidIBA 01/2022 - 11/2019
2	Hyaluronic Acid (Hyaluronan)IBA 01/2021 - 09/2014
2	AGRO 100IBA 01/2021 - 03/2017
2	CelluloseIBA 01/2021 - 11/2019
2	VaccinesIBA 09/2020 - 01/2019
2	Anti-Bacterial Agents (Antibiotics)IBA 01/2020 - 05/2018
2	Indicators and Reagents (Reagents)IBA 01/2020 - 04/2017
2	N-end cysteine peptide tumor-homing peptideIBA 01/2019 - 04/2015
2	Methotrexate (Mexate)FDA LinkGeneric 11/2017 - 04/2015
2	Carbonic Anhydrase IXIBA 06/2017 - 04/2017
2	Atorvastatin (Lipitor)FDA Link 01/2017 - 05/2014
2	Celecoxib (Celebrex)FDA Link 01/2017 - 05/2014
2	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 10/2016 - 01/2016
2	Hormones (Hormone)IBA 01/2016 - 11/2014
2	IncretinsIBA 01/2016 - 11/2014
2	Glucagon-Like Peptide 1 (GLP 1)IBA 01/2016 - 11/2014
2	6-chloro-2-(1-piperazinyl)pyrazine (CPP)IBA 12/2015 - 01/2015
1	Methylprednisolone FDA LinkGeneric 10/2022
1	Antiviral Agents (Antivirals)IBA 04/2022
1	CaspasesIBA 01/2022
1	Adenosine Monophosphate (AMP)IBA 01/2022
1	Glycated Hemoglobin (Glycosylated Hemoglobin)IBA 01/2022
1	S-NitrosothiolsIBA 01/2022
1	Exenatide (Byetta)FDA Link 01/2022
1	Paclitaxel (Taxol)FDA LinkGeneric 12/2021
1	Neuropilin-1IBA 12/2021
1	Lipid NanoparticlesIBA 12/2021
1	Mannose ReceptorIBA 10/2021
1	resiquimodIBA 10/2021
1	Interleukin-10 (Interleukin 10)IBA 10/2021
1	peptide AIBA 03/2021
1	Messenger RNA (mRNA)IBA 01/2021
1	sulfoenolpyruvateIBA 01/2021
1	GelatinIBA 01/2021
1	OligonucleotidesIBA 01/2021

Therapy/Procedure

41	Therapeutics 10/2022 - 10/2012
7	Precision Medicine 01/2021 - 04/2015
6	Immunotherapy 03/2022 - 01/2017
4	Drug Therapy (Chemotherapy) 10/2021 - 01/2019
4	Lasers (Laser) 03/2021 - 01/2018
4	Photothermal Therapy 02/2020 - 01/2018
3	Microspheres (Microsphere) 10/2022 - 01/2017
2	Injections 01/2021 - 02/2019
2	Intravenous Administration 01/2021 - 01/2019